$TRTX
TPG RE Finance Trust, Inc. Stock $trtx

$trtx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000163047223000012 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$103.2M	$95.25M
YoY Change	54.84%	56.05%
Cost Of Revenue	$7.811M	$7.212M
YoY Change	-38.41%	-1.86%
Gross Profit	$95.39M	$88.03M
YoY Change	76.76%	63.98%
Gross Profit Margin	92.43%	92.43%
Selling, General & Admin	$3.074M	$2.700M
YoY Change	35.0%	10.88%
% of Gross Profit	3.22%	3.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$200.0K
YoY Change
% of Gross Profit	0.21%
Operating Expenses	$4.922M	$2.700M
YoY Change	116.16%	10.88%
Operating Profit	$90.47M	$85.33M
YoY Change	75.02%	66.5%
Interest Expense	-$70.57M	$69.99M
YoY Change	-351.96%	211.05%
% of Operating Profit	-78.0%	82.02%
Other Income/Expense, Net	$12.73M	$9.912M
YoY Change	-14.88%	1.31%
Pretax Income	-$69.17M	$7.559M
YoY Change	1201.13%	-68.33%
Income Tax	$5.000K	$184.0K
% Of Pretax Income		2.43%
Net Earnings	-$72.72M	$7.375M
YoY Change	1238.31%	-68.99%
Net Earnings / Revenue	-70.47%	7.74%
Basic Earnings Per Share	-$0.94	$0.05
Diluted Earnings Per Share	-$0.94	$0.05
COMMON SHARES
Basic Shares Outstanding	77.41M shares	77.41M shares
Diluted Shares Outstanding	77.42M shares	78.09M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$307.4M	$161.5M
YoY Change	-13.64%	-54.06%
Cash & Equivalents	$307.4M	$161.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$83.50M	$96.26M
Other Receivables	$34.82M	$36.58M
Total Short-Term Assets	$425.8M	$294.4M
YoY Change	-33.95%	-22.94%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$242.0K	$642.0K
YoY Change	-69.33%	-24.2%
Total Long-Term Assets	$4.558B	$5.089B
YoY Change	-4.05%	-0.85%
TOTAL ASSETS
Total Short-Term Assets	$425.8M	$294.4M
Total Long-Term Assets	$4.558B	$5.089B
Total Assets	$4.984B	$5.384B
YoY Change	-7.62%	-2.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.949M	$6.019M
YoY Change	-46.11%	-2.18%
Accrued Expenses	$44.60M	$37.50M
YoY Change	102.53%	121.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$69.52M	$62.50M
YoY Change	34.24%	49.58%
LONG-TERM LIABILITIES
Long-Term Debt	$3.693B	$4.009B
YoY Change	-5.31%	0.15%
Other Long-Term Liabilities	$1.547M	$2.736M
YoY Change	45.39%	53.36%
Total Long-Term Liabilities	$3.695B	$4.012B
YoY Change	-5.3%	0.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$69.52M	$62.50M
Total Long-Term Liabilities	$3.695B	$4.012B
Total Liabilities	$3.764B	$4.075B
YoY Change	-4.78%	0.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$501.1M	-$409.8M
YoY Change	83.78%	67.03%
Common Stock	$77.00K	$77.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.220B	$1.309B
YoY Change
Total Liabilities & Shareholders Equity	$4.984B	$5.384B
YoY Change	-7.62%	-2.38%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$72.72M	$7.375M
YoY Change	1238.31%	-68.99%
Depreciation, Depletion And Amortization	$200.0K
YoY Change
Cash From Operating Activities	$7.313M	$23.47M
YoY Change	-77.47%	-28.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$479.6M	$61.60M
YoY Change	378.51%	-129.93%
Cash From Investing Activities	$479.6M	$61.60M
YoY Change	378.51%	-129.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-341.4M	-$177.2M
YoY Change	166.05%	-166.98%
NET CHANGE
Cash From Operating Activities	7.313M	$23.47M
Cash From Investing Activities	479.6M	$61.60M
Cash From Financing Activities	-341.4M	-$177.2M
Net Change In Cash	145.5M	-$92.15M
YoY Change	3234.58%	-200.84%
FREE CASH FLOW
Cash From Operating Activities	$7.313M	$23.47M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001630472
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38156
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TPG RE Finance Trust, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4796967
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	888 Seventh Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	35th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10106
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	601-4700
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	77414006	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	161524000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	254050000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	642000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	265000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	12000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	666000	usd
CY2023Q1	trtx	Collateralized Loan Obligation Proceeds Held At Trustee1 CollateralizedLoanObligationProceedsHeldAtTrustee1	367715000	usd
CY2022Q4	trtx	Collateralized Loan Obligation Proceeds Held At Trustee1 CollateralizedLoanObligationProceedsHeldAtTrustee1	297168000	usd
CY2023Q1	trtx	Accounts Receivable From Servicer Or Trustee AccountsReceivableFromServicerOrTrustee	96245000	usd
CY2022Q4	trtx	Accounts Receivable From Servicer Or Trustee AccountsReceivableFromServicerOrTrustee	163648000	usd
CY2023Q1	trtx	Accrued Interest And Fees Receivable AccruedInterestAndFeesReceivable	36582000	usd
CY2022Q4	trtx	Accrued Interest And Fees Receivable AccruedInterestAndFeesReceivable	41742000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	4916444000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	4978674000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	201508000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	197272000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	4714936000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	4781402000	usd
CY2023Q1	trtx	Real Estate Owned RealEstateOwned	0	usd
CY2022Q4	trtx	Real Estate Owned RealEstateOwned	0	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	6116000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	6197000	usd
CY2023Q1	us-gaap	Assets Assets	5383772000	usd
CY2022Q4	us-gaap	Assets Assets	5545138000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	10556000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	11080000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	26948000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	25132000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	2230426000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	2452212000	usd
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1238234000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1147288000	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	540822000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	561017000	usd
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	6019000	usd
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	5984000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	2736000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1459000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	18974000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	18970000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4074715000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4223142000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	302500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	302500000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77414006	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77414006	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77410282	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77410282	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	77000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	77000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1718742000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1716938000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-409770000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-395027000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1309057000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1321996000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1309057000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1321996000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5383772000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5545138000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	91726000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	61017000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	69990000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	22501000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21736000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	38516000	usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	3519000	usd
CY2022Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	18000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	3519000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	18000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	1330000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	1146000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	896000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1169000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1804000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1266000	usd
CY2023Q1	trtx	Servicing And Asset Management Fees ServicingAndAssetManagementFees	-137000	usd
CY2022Q1	trtx	Servicing And Asset Management Fees ServicingAndAssetManagementFees	494000	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	6019000	usd
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5709000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	9912000	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	9784000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	7784000	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4884000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7559000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23866000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	184000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	85000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7375000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	23781000	usd
CY2023Q1	trtx	Preferred Stock Dividends And Participating Securities Share In Earnings Loss PreferredStockDividendsAndParticipatingSecuritiesShareInEarningsLoss	3552000	usd
CY2022Q1	trtx	Preferred Stock Dividends And Participating Securities Share In Earnings Loss PreferredStockDividendsAndParticipatingSecuritiesShareInEarningsLoss	3345000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3823000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20436000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77410406	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77183957	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78089651	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81788723	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7375000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	23781000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7375000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23781000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1321996000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1804000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7375000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3148000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	18970000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1309057000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1464706000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1266000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	23781000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3148000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.24
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	18697000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1467908000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	7375000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	23781000	usd
CY2023Q1	trtx	Amortization And Accretion Of Premiums Discounts And Loan Origination Fees Net AmortizationAndAccretionOfPremiumsDiscountsAndLoanOriginationFeesNet	4156000	usd
CY2022Q1	trtx	Amortization And Accretion Of Premiums Discounts And Loan Origination Fees Net AmortizationAndAccretionOfPremiumsDiscountsAndLoanOriginationFeesNet	1491000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3650000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4521000	usd
CY2023Q1	trtx	Decrease Increase Of Accrued Capitalized Interest DecreaseIncreaseOfAccruedCapitalizedInterest	-542000	usd
CY2022Q1	trtx	Decrease Increase Of Accrued Capitalized Interest DecreaseIncreaseOfAccruedCapitalizedInterest	-313000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1804000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1266000	usd
CY2023Q1	trtx	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	7784000	usd
CY2022Q1	trtx	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	4884000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-954000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-5963000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3310000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1312000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	809000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	61596000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-524000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	546000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	35000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	544000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1277000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	418000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-81000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-301000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23473000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32617000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	109922000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	223871000	usd
CY2023Q1	trtx	Payments For Advances On Loans Held For Investment PaymentsForAdvancesOnLoansHeldForInvestment	51524000	usd
CY2022Q1	trtx	Payments For Advances On Loans Held For Investment PaymentsForAdvancesOnLoansHeldForInvestment	29235000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	223042000	usd
CY2022Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	47294000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-205812000	usd
CY2023Q1	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	223042000	usd
CY2022Q1	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	637906000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of First Mortgage Bond ProceedsFromIssuanceOfFirstMortgageBond	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of First Mortgage Bond ProceedsFromIssuanceOfFirstMortgageBond	907031000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	6628000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
CY2023Q1	trtx	Payment For Proceeds From Financing Costs PaymentForProceedsFromFinancingCosts	86000	usd
CY2022Q1	trtx	Payment For Proceeds From Financing Costs PaymentForProceedsFromFinancingCosts	9092000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-177218000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	264575000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92149000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	91380000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	254315000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261039000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162166000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	352419000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	66856000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	17490000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	784000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000	usd
CY2023Q1	trtx	Collateralized Loan Obligation Proceeds Held At Trustee CollateralizedLoanObligationProceedsHeldAtTrustee	70547000	usd
CY2022Q1	trtx	Collateralized Loan Obligation Proceeds Held At Trustee CollateralizedLoanObligationProceedsHeldAtTrustee	56000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	18974000	usd
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	18701000	usd
CY2023Q1	trtx	Principal Repayments Of Loans Held For Investment Held By Servicer Trustee Net PrincipalRepaymentsOfLoansHeldForInvestmentHeldByServicerTrusteeNet	66285000	usd
CY2022Q1	trtx	Principal Repayments Of Loans Held For Investment Held By Servicer Trustee Net PrincipalRepaymentsOfLoansHeldForInvestmentHeldByServicerTrusteeNet	348000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	286000	usd
CY2022Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	711000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires estimates of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from management’s estimates, and such differences could be material. Significant estimates made in the consolidated financial statements include, but are not limited to, the adequacy of our allowance for credit losses and the valuation inputs related thereto and the valuation of financial instruments. Actual amounts and values as of the balance sheet dates may be materially different from the amounts and values reported due to the inherent uncertainty in the estimation process and the limited availability of observable pricing inputs due to the nature of transitional mortgage loans. Also, future amounts and values could differ materially from those estimates due to changes in values and circumstances after the balance sheet date and the limited availability of observable prices.</span></div>
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses for Loans Held for Investment</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its allowance for credit losses on loans held for investment using the Current Expected Credit Loss model of ASC Topic 326, Financial Instruments-Credit Losses (“ASC 326”). Periodic changes to the CECL reserve are recognized through net income on the Company’s consolidated statements of income and comprehensive income. The allowance for credit losses measured under the CECL accounting framework represents an estimate of current expected losses for the Company’s existing portfolio of loans held for investment, and is presented as a valuation reserve on the Company’s consolidated balance sheets. Expected credit losses related to non-cancelable unfunded loan commitments are accounted for as separate liabilities included in accrued expenses and other liabilities on the consolidated balance sheets. The allowance for credit losses for loans held for investment, as reported in the Company’s consolidated balance sheets, is adjusted by a credit loss benefit (expense), which is reported in earnings in the consolidated statements of income and comprehensive income and reduced by the write-off of loan amounts, net of recoveries and additions related to purchased credit-deteriorated (“PCD”) assets, if relevant. The Company has elected to not measure an allowance for credit losses on accrued interest receivables related to all of its loans held for investment because it writes off uncollectible accrued interest receivable in a timely manner pursuant to its non-accrual policy, described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers key credit quality indicators in underwriting loans and estimating credit losses, including but not limited to: the capitalization of borrowers and sponsors; the expertise of the borrowers and sponsors in a particular real estate sector and geographic market; collateral type; geographic region; use and occupancy of the property; property market value; loan-to-value (“LTV”) ratio; loan amount and lien position; debt service coverage ratio; the Company’s risk rating for the same and similar loans; and prior experience with the borrower and sponsor. This information is used to assess the financial and operating capability, experience and profitability of the sponsor/borrower. Ultimate repayment of the Company’s loans is sensitive to interest rate changes, general economic conditions, liquidity, LTV ratio, existence of a liquid investment sales market for commercial properties, and availability of replacement short-term or long-term financing. The loans in the Company’s commercial mortgage loan portfolio are secured by collateral of the following property types: office; life science; multifamily; hotel; industrial; mixed-use; land for industrial and office use; and self storage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s loans are typically collateralized by real estate, or in the case of mezzanine loans, by a partnership interest or similar equity interest in the entity that owns the real estate securing the Company's first mortgage loan. The Company regularly evaluates on a loan-by-loan basis, typically no less frequently than quarterly, the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral property, and the financial and operating capability of the borrower/sponsor. The Company also evaluates the financial strength of loan guarantors, if any, and the borrower’s competency in managing and operating the property or properties. In addition, the Company considers the overall economic environment, real estate sector, and geographic sub-market in which the borrower operates. Such analyses are completed and reviewed by asset management personnel and evaluated by senior management, who utilize various data sources, including, to the extent available (i) periodic financial data such as property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections, (iii) sales and financing comparables, (iv) current credit spreads for refinancing and (v) other market data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly, the Company evaluates the risk of all loans and assigns a risk rating based on a variety of factors, grouped as follows: (i) loan and credit structure, including the as-is LTV structural features; (ii) quality and stability of real estate value and operating cash flow, including debt yield, property type, dynamics of the geography, local market, physical condition, stability of cash flow, leasing velocity and quality and diversity of tenancy; (iii) performance against underwritten business plan; (iv) the frequency and materiality of loan modifications or waivers occasioned by unfavorable variances between the underwritten business plan and actual performance; (v) changes in the capital markets that may impact the repayment of the loan via a refinancing, or sale of the loan collateral; and (vi) quality, experience and financial condition of sponsor, borrower and guarantor(s). Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from least risk to greatest risk, respectively:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.17pt">Very Low Risk</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.17pt">Low Risk</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.17pt">Medium Risk</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.17pt">High Risk/Potential for Loss—A loan that has a high risk of realizing a principal loss; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.17pt">Default/Loss Likely—A loan that has a very high risk of realizing a principal loss or has otherwise incurred a principal loss.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally assigns a risk rating of “3” to all loan investments upon origination or acquisition, except when specific circumstances warrant an exception. During the three months ended March 31, 2023, the Company simplified its risk rating definitions. The Company re-evaluated its risk ratings based on the simplified definitions and concluded that there was no impact to prior period risk ratings.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s CECL reserve also reflects estimates of the current and future economic conditions that impact the performance of the commercial real estate assets securing the Company’s loans. These estimates include unemployment rates, inflation rates, interest rates, price indices for commercial property, current and expected future availability of liquidity in the commercial property debt and equity capital markets, and other macroeconomic factors that may influence the likelihood and magnitude of potential credit losses for the Company’s loans during their anticipated term. The Company licenses certain macroeconomic financial forecasts to inform its view of the potential future impact that broader economic conditions may have on its loan portfolio’s performance. Selection of the economic forecast or forecasts used, in conjunction with loan level inputs, to determine the CECL reserve requires significant judgment about future events that, while based on the information available to the Company as of the balance sheet date, are ultimately unknowable with certainty. The actual economic conditions impacting the Company’s portfolio could vary significantly from the estimates the Company made for the periods presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs to the Company's estimation of its allowance for credit losses as of March 31, 2023 were impacted by dislocations in the capital markets, increased interest rates, continuing inflationary trends, a heightened risk of recession, recent distress in the banking sector, and geopolitical conflicts. Inherent uncertainty in the estimation process and the limited availability of observable pricing inputs due to the nature of transitional mortgage loans also constrain the Company's ability to estimate key inputs utilized to calculate its allowance for credit losses. Key inputs to the estimate include, but are not limited to: LTV; debt service coverage ratio; current and future operating cash flow and performance of collateral properties; the financial strength and liquidity of borrowers and sponsors; capitalization rates and discount rates used to value commercial real estate properties; and market liquidity based on market indices or observable transactions involving the sale or financing of commercial properties. Estimates made by the Company are subject to change. Actual results could differ from management’s estimates, and such differences could be material.</span></div>
CY2023Q1	trtx	Percentage Of Senior Mortgage Loan Transferred To Third Party PercentageOfSeniorMortgageLoanTransferredToThirdParty	1
CY2023Q1	trtx	Maximum Insured Amount Of Each Cash Account MaximumInsuredAmountOfEachCashAccount	250000	usd
CY2022Q4	trtx	Maximum Insured Amount Of Each Cash Account MaximumInsuredAmountOfEachCashAccount	250000	usd
CY2023Q1	us-gaap	Cash Cash	29000000	usd
CY2022Q4	us-gaap	Cash Cash	22400000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	600000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	161500000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	300000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	254100000	usd
CY2022Q4	trtx	Number Of Non Consolidated Senior Interest NumberOfNonConsolidatedSeniorInterest	0	loan
CY2023Q1	trtx	Number Of Non Consolidated Senior Interest NumberOfNonConsolidatedSeniorInterest	0	loan
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1200000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	1700000	usd
CY2023Q1	trtx	Percentage Of Loans Subject To Yield Maintenance Or Other Prepayment Restrictions PercentageOfLoansSubjectToYieldMaintenanceOrOtherPrepaymentRestrictions	0.338
CY2023Q1	trtx	Percentage Of Loans Open To Repayment By Borrower Without Penalty PercentageOfLoansOpenToRepaymentByBorrowerWithoutPenalty	0.662
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	4781402000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	109922000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	51524000	usd
CY2023Q1	trtx	Mortgage Loans On Real Estate Amortization Of Origination Fees MortgageLoansOnRealEstateAmortizationOfOriginationFees	4156000	usd
CY2023Q1	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	225410000	usd
CY2023Q1	trtx	Mortgage Loans On Real Estate Collection Of Accrued Paid In Kind Interest MortgageLoansOnRealEstateCollectionOfAccruedPaidInKindInterest	542000	usd
CY2023Q1	trtx	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Collection Of Cost Recovery Proceeds SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateCollectionOfCostRecoveryProceeds	1880000	usd
CY2023Q1	trtx	Mortgage Loans On Real Estate Change In Allowance For Credit Losses MortgageLoansOnRealEstateChangeInAllowanceForCreditLosses	-4236000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	4714936000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	7800000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	7900000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-15400000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-18200000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	109968000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	997858000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1855117000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	289377000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1216083000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	448041000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	4916444000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1006831000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1905539000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	289315000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1216490000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	508957000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	51542000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	4978674000	usd
CY2023Q1	trtx	Weighted Average Risk Rating WeightedAverageRiskRating	3.2	rating
CY2023Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	4939650000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	5004798000	usd
CY2023Q1	trtx	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	7800000	usd
CY2023Q1	trtx	Financing Receivable Allowance For Credit Loss Increase Decrease From Macroeconomic Events FinancingReceivableAllowanceForCreditLossIncreaseDecreaseFromMacroeconomicEvents	-29100000	usd
CY2023Q1	trtx	Financing Receivable Allowance For Credit Loss Increase Decrease Increased Loan Origination FinancingReceivableAllowanceForCreditLossIncreaseDecreaseIncreasedLoanOrigination	800000	usd
CY2023Q1	trtx	Financing Receivable Allowance For Credit Loss Increase Decrease Individually Asses Loans FinancingReceivableAllowanceForCreditLossIncreaseDecreaseIndividuallyAssesLoans	-20500000	usd
CY2023Q1	trtx	Financing Receivable Allowance For Credit Loss Increase Decrease Increased Repayments FinancingReceivableAllowanceForCreditLossIncreaseDecreaseIncreasedRepayments	-1500000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	51100000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	46200000	usd
CY2022Q1	trtx	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	4900000	usd
CY2023Q1	trtx	Number Of Loans Satisfying Criteria For Individual Assessment NumberOfLoansSatisfyingCriteriaForIndividualAssessment	4	loan
CY2023Q1	trtx	Number Of Loans On Non Accrual Status NumberOfLoansOnNonAccrualStatus	3	loan
CY2023Q1	trtx	Number Of Loans Satisfying Criteria For Individual Assessment NumberOfLoansSatisfyingCriteriaForIndividualAssessment	4	loan
CY2023Q1	trtx	Number Of Loans On Cost Recovery Status NumberOfLoansOnCostRecoveryStatus	2	loan
CY2023Q1	trtx	Number Of Loans Satisfying Criteria For Individual Assessment NumberOfLoansSatisfyingCriteriaForIndividualAssessment	4	loan
CY2022Q4	trtx	Loans Accrued Interest Income LoansAccruedInterestIncome	0	usd
CY2023Q1	trtx	Loans Accrued Interest Income LoansAccruedInterestIncome	0	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	4916444000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	4978674000	usd
CY2023Q1	trtx	Paid In Kind Interest Accrued PaidInKindInterestAccrued	0	usd
CY2022Q4	trtx	Paid In Kind Interest Outstanding PaidInKindInterestOutstanding	1714000	usd
CY2023Q1	trtx	Paid In Kind Interest Repayment PaidInKindInterestRepayment	542000	usd
CY2023Q1	trtx	Paid In Kind Interest Outstanding PaidInKindInterestOutstanding	1172000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	7700000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9000000	usd
CY2023Q1	trtx	Other Loan Held For Investment Net OtherLoanHeldForInvestmentNet	1000000	usd
CY2023Q1	trtx	Participating Mortgage Loans Minimum Conversion ParticipatingMortgageLoansMinimumConversion	0.50
CY2022Q4	trtx	Participating Mortgage Loans Minimum Conversion ParticipatingMortgageLoansMinimumConversion	0.50
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4024192000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4179211000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	905997000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	961289000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1137487000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	296451000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	29110000	usd
CY2023Q1	trtx	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	693858000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	4024192000	usd
CY2023Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	95600000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	145100000	usd
CY2023Q1	trtx	Threshold Period Of Delinquency To Consider Loan Nonperforming And Place On Nonaccrual Status ThresholdPeriodOfDelinquencyToConsiderLoanNonperformingAndPlaceOnNonaccrualStatus	P90D
CY2023Q1	trtx	Loans Held For Investment Fair Value Disclosure Nonrecurring LoansHeldForInvestmentFairValueDisclosureNonrecurring	4900000000	usd
CY2022Q4	trtx	Loans Held For Investment Fair Value Disclosure Nonrecurring LoansHeldForInvestmentFairValueDisclosureNonrecurring	4900000000	usd
CY2023Q1	trtx	Loans Held For Investment Weighted Average Gross Credit Spread LoansHeldForInvestmentWeightedAverageGrossCreditSpread	0.0351
CY2022Q4	trtx	Loans Held For Investment Weighted Average Gross Credit Spread LoansHeldForInvestmentWeightedAverageGrossCreditSpread	0.0344
CY2023Q1	trtx	Loans Held For Investment Weighted Average Maturity Period LoansHeldForInvestmentWeightedAverageMaturityPeriod	P2Y8M12D
CY2022	trtx	Loans Held For Investment Weighted Average Maturity Period LoansHeldForInvestmentWeightedAverageMaturityPeriod	P2Y9M18D
CY2023Q1	trtx	Excise Tax Percentage ExciseTaxPercentage	1
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2023Q1	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	200000	usd
CY2022Q1	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	100000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.004
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13300000	usd
CY2023Q1	trtx	Remaining Capital Loss Carry Forwards RemainingCapitalLossCarryForwards	174300000	usd
CY2023Q1	trtx	Incentive Management Fee Percentage Of Core Earnings Less Seven Percent Of Stockholders Equity IncentiveManagementFeePercentageOfCoreEarningsLessSevenPercentOfStockholdersEquity	0.20
CY2023Q1	trtx	Management Fees And Incentive Management Fees Incurred ManagementFeesAndIncentiveManagementFeesIncurred	6019000	usd
CY2022Q1	trtx	Management Fees And Incentive Management Fees Incurred ManagementFeesAndIncentiveManagementFeesIncurred	5709000	usd
CY2023Q1	trtx	Management Fees And Incentive Management Fees Paid ManagementFeesAndIncentiveManagementFeesPaid	5984000	usd
CY2022Q1	trtx	Management Fees And Incentive Management Fees Paid ManagementFeesAndIncentiveManagementFeesPaid	5609000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	400000	usd
CY2023Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	400000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	200000	usd
CY2022Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	200000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7375000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	23781000	usd
CY2023Q1	trtx	Dividends Preferred Stock Paid And Accrued DividendsPreferredStockPaidAndAccrued	3148000	usd
CY2022Q1	trtx	Dividends Preferred Stock Paid And Accrued DividendsPreferredStockPaidAndAccrued	3148000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	404000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	197000	usd
CY2023Q1	us-gaap	Undistributed Earnings UndistributedEarnings	3823000	usd
CY2022Q1	us-gaap	Undistributed Earnings UndistributedEarnings	20436000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77410406	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77183957	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	679245	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4604766	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78089651	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81788723	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2020Q2	trtx	Number Of Tranches NumberOfTranches	3	tranche
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	19000000	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	18700000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	19000000	usd
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	4939650000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	19000000	usd
CY2023Q1	trtx	Dividends Common Stock Paidinkind Shares DividendsCommonStockPaidinkindShares	3724	shares
CY2023Q1	trtx	Unfunded Commitments Loans Held For Investment UnfundedCommitmentsLoansHeldForInvestment	353900000	usd
CY2022Q4	trtx	Unfunded Commitments Loans Held For Investment UnfundedCommitmentsLoansHeldForInvestment	426100000	usd
CY2023Q1	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5294242000	usd
CY2023Q1	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	353884000	usd
CY2023Q1	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2023Q1	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2022Q4	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5429146000	usd
CY2022Q4	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	426061000	usd
CY2022Q4	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	5004798000	usd
CY2022Q4	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2023Q1	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1200000	usd
CY2022Q4	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1700000	usd
CY2023Q1	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5294242000	usd
CY2023Q1	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	353884000	usd
CY2023Q1	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	4939650000	usd
CY2023Q1	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2022Q4	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5429146000	usd
CY2022Q4	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	426061000	usd
CY2022Q4	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	5004798000	usd
CY2022Q4	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2023Q1	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1200000	usd
CY2022Q4	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1700000	usd
CY2023Q1	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5294242000	usd
CY2023Q1	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	353884000	usd
CY2023Q1	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	4939650000	usd
CY2023Q1	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2022Q4	trtx	Loan Commitment Principal Amount LoanCommitmentPrincipalAmount	5429146000	usd
CY2022Q4	trtx	Unfunded Commitments Related To Loans Receivable UnfundedCommitmentsRelatedToLoansReceivable	426061000	usd
CY2022Q4	trtx	Percentage Of Loan Commitment Principal Amount PercentageOfLoanCommitmentPrincipalAmount	1.000
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	5004798000	usd
CY2022Q4	trtx	Percentage Of Loans And Leases Receivable Unpaid Principal Balance PercentageOfLoansAndLeasesReceivableUnpaidPrincipalBalance	1.000
CY2023Q1	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1200000	usd
CY2022Q4	trtx	Loan Commitment Capitalized Interest Costs LoanCommitmentCapitalizedInterestCosts	1700000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001630472-23-000012-index-headers.html	Edgar Link	pending
0001630472-23-000012-index.html	Edgar Link	pending
0001630472-23-000012.txt	Edgar Link	pending
0001630472-23-000012-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trtx-20230331.htm	Edgar Link	pending
trtx-20230331.xsd	Edgar Link	pending
trtx-20230331ex311.htm	Edgar Link	pending
trtx-20230331ex312.htm	Edgar Link	pending
trtx-20230331ex321.htm	Edgar Link	pending
trtx-20230331ex322.htm	Edgar Link	pending
trtx-20230331_g1.jpg	Edgar Link	pending
trtx-20230331_cal.xml	Edgar Link	unprocessable
trtx-20230331_def.xml	Edgar Link	unprocessable
trtx-20230331_lab.xml	Edgar Link	unprocessable
trtx-20230331_pre.xml	Edgar Link	unprocessable
trtx-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRTX
TPG RE Finance Trust, Inc. Stock $trtx

2023 Q2 Form 10-Q Financial Statement

#000163047223000012 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRTX TPG RE Finance Trust, Inc. Stock $trtx

2023 Q2 Form 10-Q Financial Statement

#000163047223000012 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRTX
TPG RE Finance Trust, Inc. Stock $trtx